Brooklyn ImmunoTherapeutics OverviewBrooklyn ImmunoTherapeutics Net Income
Profitability analysis for BTX.
Quarterly Net Income
-$26.60M
↓ 375.84% YoY
As of Sep 2024
Annual Net Income (TTM)
-$44.93M
↓ 124.62% YoY
Trailing 12 months ending Sep 2024
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...